Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Hongtao Liu

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Liu, Hongtao

PropertyValue
keywords Stem Cell Transplantation, Hematopoietic
keywords prevention of disease relapse after chemotherapy and stem cell transplant
overview Hongtao Liu, MD, PhD, is a hematologist and medical oncologist, specializing in the diagnosis and treatment of leukemia, stem cell transplantation and cellular therapy. Dr. Liu is currently assistant professor of medicine at University of Chicago. He received MD and Ph.D in immunology from Beijing Medical University, he finished his hematology/oncology fellowship training at University of Chicago. In addition to his clinical role, Dr. Liu is an active researcher. He aims to develop immunotherapy to eliminate minimal residual diseases after chemotherapy or stem cell transplant to fight cancer cells and prevent disease relapse. Dr. Liu has received funding for his work from prominent organizations, including the American Cancer Society, Cancer Research Foundation, and K12 Paul Calabresi Career Development in Clinical Oncology Award. He has been the principal investigator for several investigator-initiated clinical trials focusing on immunotherapy and maintenance therapy to prevent disease relapse in acute leukemia after chemotherapy and stem cell transplantation. He is the national PI of the NCI 9706 REMAIN trial to use PD1 antibody, nivolumab, as maintenance treatment to prevent disease relapse in patients with AML. He is a member of ASH, ASCO, ASBMT and CAHON.

One or more keywords matched the following items that are connected to Liu, Hongtao

Item TypeName
Concept Hematopoietic Stem Cells
Concept Hematopoietic Stem Cell Transplantation
Concept Stem Cell Transplantation
Concept Peripheral Blood Stem Cell Transplantation
Concept Adult Stem Cells
Concept Cord Blood Stem Cell Transplantation
Academic Article Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.
Academic Article Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909.
Academic Article Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
Academic Article Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications.
Academic Article Expanded indications for allogeneic stem cell transplantation in patients with myeloid malignancies.
Academic Article Microchimerism and allogeneic transplantation: we need the proof in the pudding.
Academic Article A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.
Academic Article Treatments of disease relapse after allogeneic stem cell transplantation focusing on donor lymphocyte infusion.
Academic Article Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?
Academic Article Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients.
Academic Article Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.
Academic Article Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
Academic Article Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
Academic Article Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessment.
Academic Article Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia.
Academic Article Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
Academic Article Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.

Search Criteria
  • Stem Cell